Besides, scRNA sequencing revealed upregulated tumor-associated pathways, including angiogenesis and epithelial-mesenchymal transition (EMT), in cells isolated from AFPGC patients compared with that from standard GC patients [26], providing the rationale of applying anti-VEGF targeted regimen in AFPGC. The gene discussed is VEGFA; the disease is gastric cancer.